Empowered Patient Podcast

Rachna Patel MD, known as the medical marijuana doctor, talks about why she is pursuing the use of cannabis in her medical practice and shares her insights about how marijuana can be used to alleviate physical and emotional pain, which patients are most likely to be helped by a medical marijuana treatment plan, advantages of cannabis over opioids, and who should use THC and CBD with caution.

@DrRachnaPatel

DrRachnaPatel.com

Ron Chabot, CEO, Addicts Like Me and Director of Business Development, Interventional Protocol Solution shares his own compelling journey from a stellar career in telemedicine to addiction and jail time to rehab that has brought him to developing the technology platform for the AddictsLike.Me support group and community with a focus on addressing multiple needs of those addicted to opioids and other substances. Ron is creating a platform for addicts to connect with other addicts with access to critical and non-critical resources while developing protocols for doctors focused on addiction.

@BostonBiolife

AddictsLike.me

Interventional Protocol Solution

BostonBiolife

Larry Wagner, National Development Manager, CAREstream America talks about using their PRO-NOX nitrous oxide and oxygen solution to relax patients and allow them to inhale the gas on demand. From plastic surgery to regenerative medicine using nitrous oxide in procedures for pain management is between sedation and anesthesia and is seen as an analgesia that is generally safe for patients as well as the doctors who are administering the gas.

CAREstream America

Boston Biolife

Cory Kidd PhD Founder and CEO Catalia Health has been exploring the use of robots and artificial intelligence for improving healthcare for over 20 years. He and his team have taken on the challenge of figuring out why people don't stay with a drug regimen for chronic conditions. Using the robot Mabu, they are able to personalize the interaction with patients to encourage healthier habits and gather data about barriers to adherence.

@CoryK @CataliaHealth

#robot #AI #Heartfailure

Catalia Health

Marty Driscoll, CEO of Spring Bank Pharmaceuticals, discusses treatments for the hepatitis B virus, a disease suffered by 250 million people globally who are chronically infected with the hepatitis B virus. Marty talks about what a functional cure for chronically infected patients means, and what Spring Bank is doing to help those affected. Spring Bank is developing a new oral drug named inarigivir that is a selective immunomodulator/encapsidation inhibitor. Inarigivir could become a key component of a future safe and simple combination treatment in an effort to substantially increase functional cure rates for patients with chronic hepatitis B and reduce their need for daily drugs.

@springbankpharm

#HBV #HepatitisB #Functionalcure #inarigivir

Spring Bank Pharmaceuticals

Michelle Niedziela, PhD, Scientific Director, HCD Research reveals the testing that pharmaceutical companies engage in to insure that tv and print ads reach their target audience. For over 20 years, HCD has been conducting research with health care professionals, patients, and caregivers using traditional market research as well as applied neuroscience tools to test engagement, understanding, and use of words and images to offer hope as well as information. It all comes down to helping pharmaceuticals develop emotional appeal and helping patients and doctors remember the name of the drug.

@HCDNeuroscience

#neuromarketing #consumer #mrx

HCD Research

Transcranial magnetic stimulation (TMS) is a method of noninvasive neuromodulation being used to treat depression. Joe Perekupka, VP of Sales Operations at Brainsway discusses their proprietary deep TMS (dTMS) technology which is able to affect areas of the brain previously unreachable by standard TMS. The Brainsway Helmet is a device approved for treatment of the many Major Depressive Disorder (MDD) patients who have failed at least one drug-based regimen. Joe discusses the reality of MDD, the significance of dTMS technology, and the benefit it brings to those who are seeking remission from MDD.

@Brainsway

#depression #MDD #mentalhealth #NAMI #mentalhealthawareness #depressionawareness #depressionisreal

Brainsway.com

Joe Krieger, President, Boston Biolife shines light on the robust world of regenerative medicine. He describes how many of the medical breakthroughs have come about because experts in diverse disciplines came together to figure out how to help the body heal itself. One key driver has been advances in sports medicine where efforts have been made to avoid surgery and replacement of body parts. Joe and his team run training programs for scientists, technology and healthcare providers to drive advances in stem cell therapies and biologics.

@Biolife

Biolife.com

Graham Dodge, Co-Founder and CEO, Sickweather is part detective and part entrepreneur. He and his team are harvesting real time data from social media to identify early warning signs of the outbreak of the flu or allergy season. Using this social surveillance along with other reported health related and historical data, Sickweather is informing individuals about their risk of getting an infectious disease based on their physical location. The question is does this kind of information change behavior or just make people nervous. The pharmaceutical companies are also using this data to inform about ad buys and promotions.

@Sickweather

Sickweather.com

Patients with non-cystic fibrosis bronchiectasis (NCFBE), a progressive pulmonary disease, currently have no treatment options in the US. Nancy Pecota, CFO of Aradigm Corporation, discusses NCFBE and what Aradigm is doing to help these patients and possibly others who have an un-diagnosed condition . Their inhalable drug Linhaliq™ is currently on the fast track for FDA approval for NCFBE. Nancy discusses Aradigm's progress to provide an effective treatment option and prevent future infections in these patients.

#bronchiectasis #NCFBE #Linhaliq #Aradigm #pulmonarydisease

Aradigm.com